. 1996 Jun 29;140(26):1350-3.

[Predictive testing for p53-mutations; ethical considerations. National Work Group Hereditary Mamma Carcinoma]

[Article in Dutch]

Affiliations

[Article in Dutch]

G M de Wert. Ned Tijdschr Geneeskd. 1996.

. 1996 Jun 29;140(26):1350-3.

No abstract available

Similar articles

[Hereditary mutations in the p53 tumor suppressor gene; significance for clinical practice. National Work Group Hereditary Mamma Carcinoma].
Menko FH, Nooy MA, Vasen HF. Menko FH, et al. Ned Tijdschr Geneeskd. 1996 Jun 29;140(26):1347-50. Ned Tijdschr Geneeskd. 1996. PMID: 8710022 Review. Dutch. No abstract available.
Genetic counselling and genetic testing in hereditary gastrointestinal cancer syndromes.
Raymond VM, Everett JN. Raymond VM, et al. Best Pract Res Clin Gastroenterol. 2009;23(2):275-83. doi: 10.1016/j.bpg.2009.02.009. Best Pract Res Clin Gastroenterol. 2009. PMID: 19414152 Review.
[Genetic testing and counseling for familial tumor syndromes].
Katai M, Sakurai A, Fukushima Y. Katai M, et al. Gan To Kagaku Ryoho. 2002 Apr;29(4):502-7. Gan To Kagaku Ryoho. 2002. PMID: 11977532 Japanese.
Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites.
Rapakko K, Allinen M, Syrjäkoski K, Vahteristo P, Huusko P, Vähäkangas K, Eerola H, Kainu T, Kallioniemi OP, Nevanlinna H, Winqvist R. Rapakko K, et al. Br J Cancer. 2001 Jan 5;84(1):116-9. doi: 10.1054/bjoc.2000.1530. Br J Cancer. 2001. PMID: 11139324 Free PMC article.
Mutations in familial cancer.
Wright PA, Wynford-Thomas D. Wright PA, et al. J Pathol. 1994 Feb;172(2):167-70. doi: 10.1002/path.1711720202. J Pathol. 1994. PMID: 8169748 No abstract available.